Serial Number | 90884754 |
Word Mark | NEUROCRINE BIOSCIENCES |
Filing Date | Monday, August 16, 2021 |
Status | 732 - THIRD EXTENSION - GRANTED |
Status Date | Tuesday, September 24, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, December 13, 2022 |
Description of Mark | The mark consists of a stylized circular spiral design with "NEUROCRINE" above "BIOSCIENCES" in block lettering to the right. |
Goods and Services | Pharmaceutical preparations for human use for treatment of schizophrenia, adjunctive treatment of schizophrenia, cognitive impairment associated with schizophrenia, epilepsy, epileptic encephalopathy with continuous spike-and-wave during sleep, SCN8A-related epilepsy with encephalopathy, focal onset seizures, Parkinson's Disease, adjunctive treatment of Parkinson's Disease, Major Depressive Disorder, anhedonia in Major Depressive Disorder, inadequate response to treatment in Major Depressive Disorder, dyskinetic cerebral palsy, and neuroimmunological and neuroendocrinological diseases, disorders, and conditions; Pharmaceutical preparations for the diagnosis, prevention and treatment of hormonal and genetic diseases, disorders and conditions; Pharmaceutical preparations for the diagnosis and prevention of psychiatric, neurological, central nervous system, and movement diseases, disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | providing medical information in the field of hormonal and genetic diseases, disorders and conditions; on-line information services, namely, providing medical information in the field of hormonal and genetic diseases, disorders and conditions |
NOT AVAILABLE | "BIOSCIENCES" |
Goods and Services | pharmaceutical drug development services in the field of hormonal and genetic diseases, disorders and conditions |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, October 5, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, October 5, 2021 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, October 5, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Neurocrine Biosciences, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | San Diego, CA 92130 |
Party Name | Neurocrine Biosciences, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | San Diego, CA 92130 |
Event Date | Event Description |
Thursday, August 19, 2021 | NEW APPLICATION ENTERED |
Wednesday, October 6, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Tuesday, October 5, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, May 3, 2022 | ASSIGNED TO EXAMINER |
Thursday, May 5, 2022 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
Thursday, May 5, 2022 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY |
Thursday, May 5, 2022 | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
Thursday, May 5, 2022 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
Saturday, November 5, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, November 4, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, November 4, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Saturday, November 5, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, November 23, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, December 13, 2022 | PUBLISHED FOR OPPOSITION |
Tuesday, December 13, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Thursday, July 20, 2023 | SOU TEAS EXTENSION RECEIVED |
Thursday, July 20, 2023 | DIVISIONAL REQUEST RECEIVED |
Thursday, July 20, 2023 | SOU EXTENSION 1 FILED |
Wednesday, August 9, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Wednesday, August 16, 2023 | DIVISIONAL PROCESSING COMPLETE |
Wednesday, August 16, 2023 | SOU EXTENSION 1 GRANTED |
Thursday, August 17, 2023 | CORRECTED NOA E-MAILED |
Thursday, August 17, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, January 17, 2024 | SOU TEAS EXTENSION RECEIVED |
Wednesday, January 17, 2024 | SOU EXTENSION 2 FILED |
Wednesday, January 17, 2024 | SOU EXTENSION 2 GRANTED |
Friday, January 19, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Friday, August 2, 2024 | SOU EXTENSION 3 FILED |
Friday, August 2, 2024 | DIVISIONAL REQUEST RECEIVED |
Friday, August 2, 2024 | SOU TEAS EXTENSION RECEIVED |
Tuesday, February 7, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Thursday, July 20, 2023 | TEAS REQUEST TO DIVIDE RECEIVED |
Friday, August 2, 2024 | TEAS REQUEST TO DIVIDE RECEIVED |
Wednesday, September 25, 2024 | DIVISIONAL PROCESSING COMPLETE |
Wednesday, September 25, 2024 | SOU EXTENSION 3 GRANTED |
Wednesday, September 25, 2024 | CORRECTED NOA E-MAILED |
Wednesday, September 25, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |